Last reviewed · How we verify

NCT04480229

Telenursing and Breast Cancer: The Turkish Case

Completed NA Last updated 21 July 2020
What this trial tests

NA trial testing Telenursing and Counseling in Breast Cancer Female in 96 participants. Completed in 22 June 2017.

Timeline
6 May 2016
Primary endpoint
20 June 2017
22 June 2017

Quick facts

Lead sponsorSaglik Bilimleri Universitesi Gulhane Tip Fakultesi
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment96
Start date6 May 2016
Primary completion20 June 2017
Estimated completion22 June 2017

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi — full company profile →

Who can join

18 and older, female only, with Breast Cancer Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to determine the effectiveness of telenursing services on chemotherapy symptoms and comfort levels in patients with breast cancer in Turkey.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Breast Cancer Female

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi Gulhane Tip Fakultesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04480229.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing